• Explore /
  • Poster
  • / Prognostic value of free testosterone (FT) levels during chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).

Prognostic value of free testosterone (FT) levels during chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).

Abstract Poster

Authors

null

Christoph Reuter

Department of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Medizinische Hochschule Hannover, Hanover, Germany

Christoph Reuter , Michael A. Morgan , Philipp Ivanyi , Viktor Grünwald , Axel S. Merseburger , Christoph A. J. von Klot

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 35, 2017 (suppl; abstr 5039)

DOI

10.1200/JCO.2017.35.15_suppl.5039

Abstract #

5039

Poster Bd #

113

Abstract Disclosures

Similar Posters

First Author: Christoph W. Reuter

First Author: Christoph W. Reuter

First Author: Christoph W. Reuter

First Author: Christoph W. Reuter